Rare diseases
Investigational molecules
Locations
353 conditions with trials, the busiest first
844 trials across Europe, recruiting first
Study on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
AustriaStudy on Izokibep for Improving Symptoms in Patients with Active Psoriatic Arthritis
BulgariaStudy on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)
BulgariaStudy on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)
BulgariaStudy on the Long-term Safety and Effectiveness of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
GermanyStudy of Lebrikizumab and Topical Corticosteroids for Children and Teens with Moderate-to-Severe Atopic Dermatitis
CzechiaStudy on the Safety and Effectiveness of ESK-001 for Adults with Systemic Lupus Erythematosus
BulgariaStudy on the Effects of Vibozilimod for Adults with Moderate to Severe Atopic Dermatitis
EstoniaPhase 2 Study of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑Synthetase Inflammatory Myositis
CzechiaJNJ-95597528 for Adults with Moderate to Severe Atopic Dermatitis
GermanyCorabotase for Moderate to Severe Glabellar Lines in Adults
FranceA study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa
BulgariaThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
